278 related articles for article (PubMed ID: 17134737)
1. The higher incidence of squamous cell carcinoma in renal transplant recipients is associated with increased telomere lengths.
Perrem K; Lynch A; Conneely M; Wahlberg H; Murphy G; Leader M; Kay E
Hum Pathol; 2007 Feb; 38(2):351-8. PubMed ID: 17134737
[TBL] [Abstract][Full Text] [Related]
2. The different telomere lengths in basal and squamous cell carcinomas also differ between the nontransplant and renal transplant population.
Perrem K; Lynch A; Al Nooh F; Leader M; Elaine Kay
Hum Pathol; 2008 Jul; 39(7):1034-41. PubMed ID: 18482746
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
4. Langerhans cells in benign, premalignant and malignant skin lesions of renal transplant recipients and the effect of retinoid therapy.
Gibson GE; O'Grady A; Kay EW; Leader M; Murphy GM
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):130-6. PubMed ID: 9553909
[TBL] [Abstract][Full Text] [Related]
5. Skin carcinoma arising from donor cells in a kidney transplant recipient.
Aractingi S; Kanitakis J; Euvrard S; Le Danff C; Peguillet I; Khosrotehrani K; Lantz O; Carosella ED
Cancer Res; 2005 Mar; 65(5):1755-60. PubMed ID: 15753371
[TBL] [Abstract][Full Text] [Related]
6. Variations in presentation of squamous cell carcinoma in situ (Bowen's disease) in immunocompromised patients.
Drake AL; Walling HW
J Am Acad Dermatol; 2008 Jul; 59(1):68-71. PubMed ID: 18440666
[TBL] [Abstract][Full Text] [Related]
7. Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma.
Euvrard S; Kanitakis J; Decullier E; Butnaru AC; Lefrançois N; Boissonnat P; Sebbag L; Garnier JL; Pouteil-Noble C; Cahen R; Morelon E; Touraine JL; Claudy A; Chapuis F
Transplantation; 2006 Apr; 81(8):1093-100. PubMed ID: 16641592
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma skin cancer after renal transplantation: a single-center experience in 1736 transplantations.
Zavos G; Karidis NP; Tsourouflis G; Bokos J; Diles K; Sotirchos G; Theodoropoulou E; Kostakis A
Int J Dermatol; 2011 Dec; 50(12):1496-500. PubMed ID: 21790552
[TBL] [Abstract][Full Text] [Related]
9. Squamous cell carcinoma in situ arising at the exit site of a tunneled catheter.
Hammes JS; Bestoso JT; Sharma A
Am J Kidney Dis; 2004 Sep; 44(3):e43-6. PubMed ID: 15332239
[TBL] [Abstract][Full Text] [Related]
10. Arsenic carcinogenesis in the skin.
Yu HS; Liao WT; Chai CY
J Biomed Sci; 2006 Sep; 13(5):657-66. PubMed ID: 16807664
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases.
Nijsten T; Colpaert CG; Vermeulen PB; Harris AL; Van Marck E; Lambert J
Br J Dermatol; 2004 Oct; 151(4):837-45. PubMed ID: 15491425
[TBL] [Abstract][Full Text] [Related]
12. Skin Cancer Risk in Hematopoietic Stem-Cell Transplant Recipients Compared With Background Population and Renal Transplant Recipients: A Population-Based Cohort Study.
Omland SH; Gniadecki R; Hædersdal M; Helweg-Larsen J; Omland LH
JAMA Dermatol; 2016 Feb; 152(2):177-83. PubMed ID: 26454261
[TBL] [Abstract][Full Text] [Related]
13. Alternative lengthening of telomeres in the human adrenocortical carcinoma cell line H295R.
Fujiwara M; Kamma H; Wu W; Yano Y; Homma S; Satoh H
Int J Oncol; 2006 Aug; 29(2):445-51. PubMed ID: 16820888
[TBL] [Abstract][Full Text] [Related]
14. Telomere dynamics in a human cancer cell line.
Sprung CN; Sabatier L; Murnane JP
Exp Cell Res; 1999 Feb; 247(1):29-37. PubMed ID: 10047445
[TBL] [Abstract][Full Text] [Related]
15. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
16. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia.
Carroll RP; Ramsay HM; Fryer AA; Hawley CM; Nicol DL; Harden PN
Am J Kidney Dis; 2003 Mar; 41(3):676-83. PubMed ID: 12612993
[TBL] [Abstract][Full Text] [Related]
17. Absence of telomerase and shortened telomeres have minimal effects on skin and pancreatic carcinogenesis elicited by viral oncogenes.
Argilla D; Chin K; Singh M; Hodgson JG; Bosenberg M; de Solórzano CO; Lockett S; DePinho RA; Gray J; Hanahan D
Cancer Cell; 2004 Oct; 6(4):373-85. PubMed ID: 15488760
[TBL] [Abstract][Full Text] [Related]
18. Analysis of skin cancer risk factors in immunosuppressed renal transplant patients shows high levels of UV-specific tandem CC to TT mutations of the p53 gene.
Queille S; Luron L; Spatz A; Avril MF; Ribrag V; Duvillard P; Hiesse C; Sarasin A; Armand JP; Daya-Grosjean L
Carcinogenesis; 2007 Mar; 28(3):724-31. PubMed ID: 17065198
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of telomerase activity in non-genital Bowen's disease.
Mitsuishi T; Nakatake M; Kaneko T; Ohara K; Kato T; Iida K; Iwabu Y; Tokunaga K; Sata T; Kawana S; Yamada O
J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):668-72. PubMed ID: 19250332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]